Lack of Clinical Benefit of Interferon β-1a among Patients with Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?

Manu Shankar-Hari; Carolyn S. Calfee

doi:10.1001/jama.2019.22524

Lack of Clinical Benefit of Interferon β-1a among Patients with Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?

Manu Shankar-Hari
, Carolyn S. Calfee

Guy’s and St Thomas NHS Foundation Trust, London, UK

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	713-715
Number of pages	3
Journal	JAMA
Volume	323
Issue number	8
DOIs	https://doi.org/10.1001/jama.2019.22524
Publication status	Published - 25 Feb 2020
Externally published	Yes

Access to Document

10.1001/jama.2019.22524

Cite this

@article{dffe4860e2364e62a12b2ebe2cc9f4f9,

title = "Lack of Clinical Benefit of Interferon β-1a among Patients with Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?",

author = "Manu Shankar-Hari and Calfee, \{Carolyn S.\}",

year = "2020",

month = feb,

day = "25",

doi = "10.1001/jama.2019.22524",

language = "English",

volume = "323",

pages = "713--715",

journal = "JAMA",

issn = "0098-7484",